China’s WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to US drug maker Merck & Co for about US$500 million, ahead of potential US legislation that would restrict ...
the Hang Seng China Enterprise ETF, Wuxi Biologics, Tencent, China National Petroleum, and Semiconductor Manufacturing International (SMIC). Shanghai, Shenzhen, and the STAR Board diverged to ...
Jan 6 (Reuters) - China's WuXi Biologics (2269.HK), opens new tab said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co (MRK.N), opens new tab for about $500 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback